7 day study of the safety, efficacy and the pharmacokinetic and pharmacodyamic properties of oral rivaroxaban in children from birth to less than 6 months with catheter-related aterial or venous thrombosis

Administered By

Awarded By

Contributors

Start/End

  • October 12, 2015 - September 10, 2018